What is Myriad Genetics's debt repayments?

Myriad Genetics (MYGN) reported debt repayments of $0 in Q1 2026.

How has Myriad Genetics's debt repayments changed year-over-year?

Myriad Genetics's debt repayments decreased by 100.0% year-over-year, from $20.5M to $0.

What is the long-term trend for Myriad Genetics's debt repayments?

Over 3 years (2021 to 2024), Myriad Genetics's debt repayments has grown at a -19.2% compound annual growth rate (CAGR), from $226.4M to $119.5M.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Myriad Genetics MYGN Debt Repayments

Debt Repayments at other companies

Labcorp HoldingsLH

$0-100%

Quest DiagnosticsDGX

$1M-99.8%

Fulgent Genetics, Inc.FLGT

$476K+1.3%

GeneDx HoldingsWGS

$2M—

Mesa LaboratoriesMLAB

$14.69M-18.1%

Opko HealthOPK

$8.88M-7.0%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLinesOfCredit.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's debt repayments?: Myriad Genetics (MYGN) reported debt repayments of $0 in Q1 2026.
How has Myriad Genetics's debt repayments changed year-over-year?: Myriad Genetics's debt repayments decreased by 100.0% year-over-year, from $20.5M to $0.
What is the long-term trend for Myriad Genetics's debt repayments?: Over 3 years (2021 to 2024), Myriad Genetics's debt repayments has grown at a -19.2% compound annual growth rate (CAGR), from $226.4M to $119.5M.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.